Progress in diagnosing and managing cardiac amyloidosis.


Journal

Cleveland Clinic journal of medicine
ISSN: 1939-2869
Titre abrégé: Cleve Clin J Med
Pays: United States
ID NLM: 8703441

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 10 1 2019
pubmed: 10 1 2019
medline: 15 1 2020
Statut: ppublish

Résumé

The last decade has seen major advances in diagnosing and treating cardiac amyloidosis. Early diagnosis can often now be made using noninvasive laboratory testing and imaging. New treatments are effective and well tolerated.

Identifiants

pubmed: 30624188
doi: 10.3949/ccjm.86gr.18004
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-37

Informations de copyright

Copyright © 2019 Cleveland Clinic.

Auteurs

Mazen Hanna (M)

Co-Director, Amyloidosis Center, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA. hammam@ccf.org.

Chetan Huded (C)

Resident Fellow, Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.

E Rene Rodriguez (ER)

Director, Cardiovascular Pathology, Director, Autopsy Pathology, Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, USA.
Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.

Dermot Phelan (D)

Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.

Deborah Kwon (D)

Director of Cardiac MRI Research, Department of Cardiovascular Medicine and Department of Diagnostic Radiology, Cleveland Clinic, Cleveland, OH, USA.
Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.

Wael Jaber (W)

Department of Cardiovascular Medicine, Heart and Vascular Institute, and Department of Nuclear Medicine, Cleveland Clinic, Cleveland, OH, USA.

Jason Valent (J)

Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.

Michael Zhen-Yu Tong (MZ)

Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH